Evidence map›Paper›PMID 32355559›Full record

ArticleClinical & translational immunology2020

Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency.

Christina Grosserichter-Wagener, Alexander Franco-Gallego, Fatemeh Ahmadi, Marcela Moncada-Vélez, Virgil Ash Dalm, Jessica Lineth Rojas, Julio César Orrego, Natalia Correa Vargas, Lennart Hammarström, Marco Wj Schreurs and 8 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19.The journal of allergy and clinical immunology. In practice · 2023
    Article
  7. Article
  8. Review
  9. CD21Frontiers in pediatrics · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Innate Mechanisms in Selective IgA Deficiency.Frontiers in immunology · 2021
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Christina Grosserichter-WagenerDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Alexander Franco-GallegoGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.
Fatemeh AhmadiDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Marcela Moncada-VélezGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.
Virgil Ash DalmDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Jessica Lineth RojasGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.
Julio César OrregoGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.
Natalia Correa VargasGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.
Lennart HammarströmClinical Immunology Department of Laboratory Medicine Karolinska Institutet at Karolinska University Hospital Huddinge Sweden.
Marco Wj SchreursDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Willem A DikDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
P Martin van HagenDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Louis BoonBioceros B.V. Utrecht The Netherlands.
Jacques Jm van DongenDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Mirjam van der BurgDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.
Qiang Pan-HammarströmClinical Immunology Department of Laboratory Medicine Karolinska Institutet at Karolinska University Hospital Huddinge Sweden.
José L FrancoGrupo de Inmunodeficiencias Primarias Universidad de Antioquia UdeA Medellín Colombia.ORCID https://orcid.org/0000-0001-5664-6415
Menno C van ZelmDepartment of Immunology Erasmus MC University Medical Center Rotterdam The Netherlands.ORCID https://orcid.org/0000-0003-4161-1919
Erasmus MC · NLUniversidad de Antioquia · COKarolinska University Hospital · SELeiden University Medical Center · NLPolpharma Biologics (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSelective IgA deficiency (sIgAD) is the most common primary immunodeficiency in Western countries. Patients can suffer from recurrent infections and autoimmune diseases because of a largely unknown aetiology. To increase insights into the pathophysiology of the disease, we studied memory B and T cells and cytokine concentrations in peripheral blood.

methodsWe analysed 30 sIgAD patients (12 children, 18 adults) through detailed phenotyping of peripheral B-cell, CD8

resultsAll patients had significantly decreased numbers of T-cell-dependent (TD; CD27

conclusionImpaired IgA memory formation in sIgAD patients is not due to a B-cell activation defect. Instead, decreased Th1 and Th17 cell numbers and high blood levels of BAFF, APRIL and TGF-β1 might reflect disturbed regulation of IgA responses

Indexed as

B‐cell memorycytokine concentrationIgAselective IgA deficiencyTh17 cellsTh1 cells

Identifiers

PMID32355559
PMCPMC7190975
OpenAlexW3022158346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.